Inactivation and purification of human immunodeficiency virus-1 as antigen for the treatment of HIV-1 infection

BioPharm

Volumn 9, Issue 9, 1996, Pages 22-34

  Prior, C P ^a   Gore, R ^a   Harter, J ^a   Berbaum, M ^a   Duffy, C ^a   Ferre, F ^a   Hancock, R ^a   Lowry, P ^a   Musil, R ^a   Stiglitz, M ^a   Carlo, D J ^a   Richieri, S P ^a   Maigetter, R Z ^a  

^a Immune Response Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS VACCINE;

ARTICLE; DRUG MANUFACTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; QUALITY CONTROL; VIRUS INACTIVATION; VIRUS PURIFICATION;

EID: 0029807857     PISSN: 10408304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)